China CAS NO 1333152-22-9 Factory

owing to fantastic assistance, a variety of high quality goods, aggressive rates and efficient delivery, we love a very good popularity among our customers. We are an energetic firm with wide market for CAS NO 1333152-22-9,1333152-22-9,Selinexor KPT330 intermediate,Selinexor KPT330 advance intermediate,(Z)-isopropyl 3, We've been looking forward to receiving your enquiries quickly.
CAS NO 1333152-22-9, Now, with the development of internet, and the trend of internationalization, we've got decided to extend business to overseas market. With the propose of bringing more profits to oversea customers by providing directly abroad. So we have changed our mind, from home to abroad, hope to give our customers more profit, and looking forward to more chance to make business.

Hot Products

  • Puerarin

    Puerarin

    Product Name:Puerarin
    Molecular Formula:C21H20O9
    Molecular Weight:416.38
    CAS Registry Number:3681-99-0
  • tert-butyl 2-amino-4-(4-methylpiperazin-1-yl)benzoate

    tert-butyl 2-amino-4-(4-methylpiperazin-1-yl)benzoate

    Product Name:tert-butyl 2-amino-4-(4-methylpiperazin-1-yl)benzoate
    Molecular Formula:C16H25N3O2
    Molecular Weight:291.39
    CAS Registry Number:1034975-35-3
  • Anthranilic acid

    Anthranilic acid

    Product Name:Anthranilic acid
    Molecular Formula:C7H7NO2
    Molecular Weight:137.14
    CAS Registry Number:118-92-3
  • N-Methylparoxetine

    N-Methylparoxetine

    Product Name:N-Methylparoxetine
    Molecular Formula:C20H22FNO3
    Molecular Weight:343.39
    CAS Registry Number:110429-36-2
  • Rifapentine

    Rifapentine

    Product Name:Rifapentine
    Molecular Formula:C47H64N4O12
    Molecular Weight;877.03
    CAS Registry Number;61379-65-5
  • Nandrolone

    Nandrolone

    Product Name:Nandrolone
    Molecular Formula:C18H26O2
    Molecular Weight:274.4
    CAS Registry Number;434-22-0

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept